Trials / Unknown
UnknownNCT05019300
Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.
Long-term Neurocognitive and Psychiatric Consequences of COVID-19 in Patients Discharged From Critical Care Units. A Cohort Study of the Advance Interdisciplinary Rehabilitation Register (AIRR) Covid-19 Working Group.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Pontificia Universidad Catolica de Chile · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Long-term neurocognitive and psychiatric consequences of COVID-19 remain mostly unknown to date. It has been reported that coronaviruses cause direct central nervous system infection (Needham et al. 2020). Besides that, new or worsening cognitive impairment commonly occurs and persists in survivors of intensive care unit (ICU) stay (Hosey \& Needham. 2020). The purpose of our study is to search and describe the cognitive and psychiatric long-term consequences of COVID-19 on patients who have been discharged from critical care units. This is an ambidirectional cohort study, that attempts to follow adults discharged from critical Care Units Adults due to COVID-19 up to 12 months after discharge, to evaluate the presence of cognitive impairment, linguistic and phonation function, depression, fatigue, functional gastroenterological symptoms, anxiety, or post traumatic disorder, and performance in activities of daily living and physical response to exercise as well.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Exposure: COVID-19 severity | COVID-19 severity between 4 to 7 points according the seven-category scale of clinical status reported by Huang et al. (2021) and severe to critical symptomatic levels on spectrum of disease reported by Wu and McGoogan (2020). |
Timeline
- Start date
- 2021-05-24
- Primary completion
- 2021-09-01
- Completion
- 2021-10-01
- First posted
- 2021-08-24
- Last updated
- 2021-08-31
Locations
1 site across 1 country: Chile
Source: ClinicalTrials.gov record NCT05019300. Inclusion in this directory is not an endorsement.